These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8499646)

  • 21. Granulocyte-macrophage colony-stimulating factor augments lymphokine-activated killer activity from pleural cavity mononuclear cells of lung cancer patients without malignant effusion.
    Takahashi K; Sone S; Saito S; Kamamura Y; Uyama T; Ogura T; Monden Y
    Jpn J Cancer Res; 1995 Sep; 86(9):861-6. PubMed ID: 7591964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant granulocyte-macrophage colony-stimulating factor down-regulates expression of IL-2 receptor on human mononuclear phagocytes by induction of prostaglandin E.
    Hancock WW; Pleau ME; Kobzik L
    J Immunol; 1988 May; 140(9):3021-5. PubMed ID: 3129507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Granulocyte-macrophage colony-stimulating factor improves immunological parameters in patients with refractory solid tumours receiving second-line chemotherapy: correlation with clinical responses.
    Baxevanis CN; Tsavaris NB; Papadhimitriou SI; Zarkadis IK; Papadopoulos NG; Bastounis EA; Papamichail M
    Eur J Cancer; 1997 Jul; 33(8):1202-8. PubMed ID: 9301443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of human blood monocytes in up-regulation of lymphokine (interleukin-2)-activated killer cell activity with cisplatin and FK-565.
    Sodhi A; Basu S
    Nat Immun; 1992; 11(2):105-16. PubMed ID: 1498519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional expression of interleukin 2 receptor in a human factor-dependent megakaryoblastic leukemia cell line: evidence that granulocyte-macrophage colony-stimulating factor inhibits interleukin 2 binding to its receptor.
    Kanakura Y; Sugahara H; Mitsui H; Ikeda H; Furitsu T; Yagura H; Kitayama H; Kanayama Y; Matsuzawa Y
    Cancer Res; 1993 Feb; 53(3):675-80. PubMed ID: 8425202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-10 inhibits spontaneous colony-forming unit-granulocyte-macrophage growth from human peripheral blood mononuclear cells by suppression of endogenous granulocyte-macrophage colony-stimulating factor release.
    Oehler L; Foedinger M; Koeller M; Kollars M; Reiter E; Bohle B; Skoupy S; Fritsch G; Lechner K; Geissler K
    Blood; 1997 Feb; 89(4):1147-53. PubMed ID: 9028936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon-gamma-induced alterations of monocyte susceptibility to lysis by autologous lymphokine-activated killer (LAK) cells.
    Djeu JY; Blanchard DK
    Int J Cancer; 1988 Sep; 42(3):449-54. PubMed ID: 3138195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer.
    Baxevanis CN; Reclos GJ; Gritzapis AD; Dedousis GV; Missitzis I; Papamichail M
    Cancer; 1993 Jul; 72(2):491-501. PubMed ID: 8319179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes.
    Suzuki H; Katayama N; Ikuta Y; Mukai K; Fujieda A; Mitani H; Araki H; Miyashita H; Hoshino N; Nishikawa H; Nishii K; Minami N; Shiku H
    Am J Hematol; 2004 Apr; 75(4):179-89. PubMed ID: 15054806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant interleukin 3 induces interleukin 2 receptor expression on early myeloid cells in normal human bone marrow.
    Gazzola MV; Collins NH; Tafuri A; Keever CA
    Exp Hematol; 1992 Feb; 20(2):201-8. PubMed ID: 1371965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Priming effects of granulocyte-macrophage colony-stimulating factor are coupled to cholera toxin-sensitive guanine nucleotide binding protein in human T lymphocytes.
    al-Aoukaty A; Giaid A; Sinoff C; Ho AD; Maghazachi AA
    Blood; 1994 Mar; 83(5):1299-309. PubMed ID: 8118033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimulation of neuronal cells by culture supernatant of T lymphocytes triggered by anti-CD3 mAb followed by propagation in the presence of interleukin-2.
    Ishiguro M; Okada A; Asai K; Kojima K; Okada H
    Microbiol Immunol; 2016 Jan; 60(1):47-55. PubMed ID: 26616436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of malignant cell clonogenic capacities and position along the maturation pathway on their susceptibility to lymphokine-activated killer cell cytotoxicity.
    Thomas X; Anglaret B; Adeleine P; Maritaz O; Bailly M; Fiere D; Archimbaud E
    Leuk Lymphoma; 1998 Jan; 28(3-4):343-53. PubMed ID: 9517505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lysis of pulmonary fibroblasts by lymphokine (IL-2)-activated killer cells--a mechanism affecting the human lung microenvironment?
    Zambello R; Trentin L; Enthammer C; Cipriani A; Agostini C; Semenzato G
    Clin Exp Immunol; 1996 Aug; 105(2):383-8. PubMed ID: 8706349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of colony-stimulating factors on cellular cytotoxicity.
    Durek C; Schäfer I; Braasch H; Ulmer AJ; Ernst M; Flad HD; Jocham D; Böhle A
    Cancer Immunol Immunother; 1997 Mar; 44(1):35-40. PubMed ID: 9111582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of lethal irradiation and cyclosporin A treatment on the growth and tumoricidal activity of a T cell clone potentially useful in cancer therapy.
    Cesano A; Visonneau S; Cioé L; Clark SC; Santoli D
    Cancer Immunol Immunother; 1995 Mar; 40(3):139-51. PubMed ID: 7728772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence that interleukin-4 suppression of lymphokine-activated killer cell induction is mediated through monocytes.
    Brooks B; Parry H; Lawry J; Rees R
    Immunology; 1992 Feb; 75(2):343-8. PubMed ID: 1551696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Granulocyte-macrophage colony-stimulating factor and interleukin-3 mRNAs are produced by a small fraction of blood mononuclear cells.
    Wimperis JZ; Niemeyer CM; Sieff CA; Mathey-Prevot B; Nathan DG; Arceci RJ
    Blood; 1989 Oct; 74(5):1525-30. PubMed ID: 2676015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytolysis of human dendritic cells by autologous lymphokine-activated killer cells: participation of both T cells and NK cells in the killing.
    Parajuli P; Nishioka Y; Nishimura N; Singh SM; Hanibuchi M; Nokihara H; Yanagawa H; Sone S
    J Leukoc Biol; 1999 Jun; 65(6):764-70. PubMed ID: 10380897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T cells and monocytes regulate the generation and functional activity of natural killer-derived lymphokine-activated killer cells.
    Atzpodien J; Gulati SC
    Stem Cells; 1993 Nov; 11(6):511-8. PubMed ID: 8111310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.